What is Congenital Pulmonary Airway Malformation (CPAM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

CPAM stands for Congenital Pulmonary Airway Malformation, a rare birth defect affecting the lungs, where abnormal lung tissue develops during fetal growth. Management of CPAM depends on the severity and symptoms:

  • For asymptomatic cases: Observation with regular follow-up imaging.
  • For symptomatic or large lesions: Surgical resection is recommended, typically performed between 3-6 months of age. Specific management steps:
  1. Prenatal diagnosis: Usually detected on routine ultrasound 1.
  2. Fetal monitoring: Regular ultrasounds to assess growth and potential complications.
  3. Postnatal evaluation: Chest X-ray and CT scan to confirm diagnosis and assess extent.
  4. Treatment decision: Based on symptoms and size of the lesion.
  5. Surgery: Lobectomy or segmentectomy to remove affected tissue.
  6. Post-operative care: Pain management, respiratory support if needed. CPAM occurs due to arrested lung development between 4-7 weeks of gestation. Early intervention is crucial to prevent complications such as recurrent infections, pneumothorax, or rarely, malignant transformation. Long-term prognosis is generally good after successful treatment. According to the Society for Maternal-Fetal Medicine (SMFM) clinical guideline #7, for fetal CPAM, macrocystic type: fetal needle drainage of effusion or placement of thoracoamniotic shunt; microcystic type: maternal administration of corticosteroids, betamethasone 12.5 mg IM q24 h 2 doses or dexamethasone 6.25 mg IM q12 h 4 doses 1. It is also noted that hydrops occurs in only about 5% of fetuses with CPAM but confers a poor prognosis without treatment 1.

From the Research

Definition and Prevalence of Congenital Pulmonary Airway Malformation (CPAM)

  • Congenital pulmonary airway malformations (CPAMs) represent a cluster of rare lung malformations affecting 1 in 2500 live births 2.
  • CPAMs include cystic and non-cystic lung lesions, accounting for about 30-40% of developmental lung bud anomaly lesions 3.

Characteristics and Natural History of CPAM

  • The natural history of many CPAMs is to increase their size in the second trimester, reach a plateau, and, in about 50% of cases, regress and become barely detectable during the third trimester 2.
  • CPAMs vary in their histological features, epidemiological and clinical presentation, severity, and prognosis, supporting the embryologic hypothesis of arrested lung growth during branching morphogenesis 3.

Diagnosis and Management of CPAM

  • CPAMs can be diagnosed prenatally using fetal ultrasound, and serial assessment of these lesions throughout pregnancy is common 4.
  • Management of CPAM is controversial, especially for asymptomatic patients, and may involve surgical resection or a conservative approach 5.
  • Surgical resection is the standard of therapy for symptomatic CPAMs, while the management of asymptomatic cases remains controversial 3.
  • A multidisciplinary team including gynecologists, neonatologists, radiologists, pediatricians, and pediatric surgeons is recommended in pre, postnatal management and in the postsurgical follow-up of all children with CPAMs 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.